Tags |
|
|
Links |
|
|
Advice Pool - Hypnosis In The Improvement Of The Quality of Life In Cancer Suffers
Between July 2005 and September 2005, nine cancer afflicted volunteers were admi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
tted for a clinical trial to assess any improvements in the quality of life with
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
the use of (non Ericksonian) hypnosis. Six 20 minute sessions were conducted on
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
each subject, over a six week period at the frequency of once a week.
The 9 pa
The 9 pa
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ticipants were both male and female aged between 38 and 76 years of age. No pre-
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
trial treatment protocols were changed, and all of the participants were require
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
d to be admitted by and continue there usual standard of care medical curative a
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
nd palliative therapies under the direction and supervision of their General Pra
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
titioners or Oncologists.
The subjects presented with various cancers at vario
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
us stages of progression or stabilisation including; Stomach cancer. Bowel cance
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
r, Lung cancer, Breast cancer, Prostate cancer, and Bone Cancer.
The intention
The intention
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
of the study was to evaluate any improvements in Insomnia, Depression, Pain, Ene
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
gy, and general quality of life. The results were extremely encouraging and redu
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ced most of the negative side effects of other treatments and general well being
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
between 60 to 100%.
The most significant improvements were seen in Nausea (red
The most significant improvements were seen in Nausea (red
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
uced 100%) Emotional Functioning (improved 70%) Insomnia (improved 75%) Appetite
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
(improved 55%) General Wellbeing (improved 65%)
Because of the promising result
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
s in 2006 a much larger clinical will be conducted in Perth Western Australia us
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ing the same protocols.
Full clinical results of the trial can be viewed at
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
target="_new" href="http://www.mindmotivations.com/">www.mindmotivations.com
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/294870/advicepool-Hypnosis-In-The-Improvement-Of-The-Quality-of-Life-In-Cancer-Suffers.html">Hypnosis In The Improvement Of The Quality of Life In Cancer Suffers</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/294870/advicepool-Hypnosis-In-The-Improvement-Of-The-Quality-of-Life-In-Cancer-Suffers.html]Hypnosis In The Improvement Of The Quality of Life In Cancer Suffers[/url]
Related Articles:
Do Manufacturing Processes Make it Impossible for Food and Drug Companies to Create Healthy Products
Why Is A Mentor Necessary To Succeed At Forex (FX) Currency Trading? (Part II)
Bookmark it:
|